Navigation Links
Immune system molecule promotes tumor resistance to anti-angiogenic therapy
Date:8/5/2013

A team of scientists, led by Napoleone Ferrara, MD, has shown for the first time that a signaling protein involved in inflammation also promotes tumor resistance to anti-angiogenic therapy.

The findings by Ferrara professor of pathology at the University of California, San Diego School of Medicine and senior deputy director for basic science at the UC San Diego Moores Cancer Center and colleagues at Genentech, a biotechnology firm based in South San Francisco, are published in the August 4 Advance Online Publication of the journal Nature Medicine.

Angiogenesis is a physiological process in which new blood vessels form from existing vessels. It is fundamental to early development and wound healing, but some cancer tumors exploit angiogenesis to promote blood vessel growth and fuel a tumor's transition from a benign to a malignant state.

In the late 1980s, Ferrara led efforts to identify a key gene (VEGF) involved in angiogenesis and subsequent development of the first drugs to block VEGF-mediated growth in a variety of cancers, among them lung, kidney, brain and colorectal. Researchers discovered, however, that similar to other therapies, VEGF-targeting drugs may lose effectiveness as tumors develop resistance, allowing cancers to recur.

The latest research highlights the role of interleukin-17 or IL-17, one of a family of signaling molecules called cytokines that are involved in the body's immune response. Ferrara and colleagues discovered that IL-17 signaling in tumor-infiltrating T cells, part of the body's adaptive immune response, encourages resistance to the VEGF-blockade in mouse models.

"Our work has the potential to have major translational and therapeutic relevance," said Ferrara. "By inhibiting the effects of IL-17 with monoclonal antibodies or other blockers, we can potentially improve the clinical efficacy of VEGF-targeting drugs."


'/>"/>

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Page: 1

Related medicine news :

1. The American Academy of Anti-Aging Medicine (A4M) to host Gut, Brain, and Autoimmune Disorders: the Role of Food Symposium in Los Angeles, CA August 16-17, 2013
2. Premature aging of immune cells in joints of kids with chronic arthritis, Pitt team says
3. Isolated psychiatric episodes rare, but possible, in common form of autoimmune encephalitis
4. Mount Sinai researchers discover mechanism behind development of autoimmune hepatitis
5. Poor sleep in pregnancy can disrupt the immune system and cause birth-related complications
6. Targeting errant immune system enzyme kills myelodysplastic cells
7. Removal of tumor-associated immune cell protein decreases tumor progression
8. Maintaining immune balance involves an unconventional mechanism of T cell regulation
9. IRCM scientists find a novel research model for the study of auto-immune diseases
10. Scientists discover new mechanism regulating the immune response
11. Modified immune cells seek and destroy melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... Charlottesville, Virginia (PRWEB) , ... January 18, 2017 , ... ... New studies are released almost daily linking gut health to chronic disease, mental health ... the New Year ” as an important resolution to consider. , For one Charlottesville ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... Maryland Fischell Department of Bioengineering are collaborating on a research project focused on ... bioengineering, the project seeks to use nanotechnology to control the disease without compromising ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... industry’s leading journal and most-read publication among specialty pharmacists and pharmacy professionals, ... through its Strategic Alliance Partnership (SAP) program, announced Brian Haug, president of ...
(Date:1/18/2017)... ... 18, 2017 , ... A Palm Beach doctor plans to run the 2017 ... that provides free surgery to poor children suffering from cleft lip and cleft palate. ... run to support the efforts of the American Heart Association and the Leukemia and ...
(Date:1/18/2017)... , ... January 18, 2017 , ... The Portee Insurance ... families and business owners in central Maryland and the DC region, is inaugurating a ... kills 787,000 people nationally every year, making it the #1 killer in America. However, ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... Research and Markets has announced the addition ... report to their offering. ... The global CINV drugs market to grow at ... Global Thoracic Surgery Market 2017-2021, has been prepared based on an ... the market landscape and its growth prospects over the coming years. ...
(Date:1/18/2017)... 17, 2017  With an annual growth ranging from 6% to 10%, ... (Jakarta International Expo, March 22-24, 2017) serves the industry by fostering the regional ... SEA 2017? Investment Forum ASEAN -- ... Richer conference content Enhanced business matchmaking program ... ...
(Date:1/18/2017)... 18, 2017   Seno Medical Instruments, Inc. , ... cancer through the development of an opto-acoustic (OA/US) imaging ... as SVP of Engineering. Mr. Miller previously served ... SonoSite, with headquarters in Bothell, Washington ... 30-year career to the development of innovative medical imaging ...
Breaking Medicine Technology: